These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial. Dilraj A; Cutts FT; de Castro JF; Wheeler JG; Brown D; Roth C; Coovadia HM; Bennett JV Lancet; 2000 Mar; 355(9206):798-803. PubMed ID: 10711928 [TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children. Wong-Chew RM; Islas-Romero R; García-García Mde L; Beeler JA; Audet S; Santos-Preciado JI; Gans H; Lew-Yasukawa L; Maldonado YA; Arvin AM; Valdespino-Gómez JL Vaccine; 2006 Jan; 24(5):683-90. PubMed ID: 16154241 [TBL] [Abstract][Full Text] [Related]
4. Aerosolized measles and measles-rubella vaccines induce better measles antibody booster responses than injected vaccines: randomized trials in Mexican schoolchildren. Bennett JV; Fernandez de Castro J; Valdespino-Gomez JL; Garcia-Garcia Mde L; Islas-Romero R; Echaniz-Aviles G; Jimenez-Corona A; Sepulveda-Amor J Bull World Health Organ; 2002; 80(10):806-12. PubMed ID: 12471401 [TBL] [Abstract][Full Text] [Related]
5. Immunization of six-month-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines. Markowitz LE; Sepulveda J; Diaz-Ortega JL; Valdespino JL; Albrecht P; Zell ER; Stewart J; Zarate ML; Bernier RH N Engl J Med; 1990 Mar; 322(9):580-7. PubMed ID: 2304505 [TBL] [Abstract][Full Text] [Related]
6. Induction of cellular and humoral immunity after aerosol or subcutaneous administration of Edmonston-Zagreb measles vaccine as a primary dose to 12-month-old children. Wong-Chew RM; Islas-Romero R; García-García Mde L; Beeler JA; Audet S; Santos-Preciado JI; Gans H; Lew-Yasukawa L; Maldonado YA; Arvin AM; Valdespino-Gómez JL J Infect Dis; 2004 Jan; 189(2):254-7. PubMed ID: 14722890 [TBL] [Abstract][Full Text] [Related]
7. [Comparative serological efficacy of the measles vaccine strains Edmonston-Zagreb, Schwarz and AIK-C in Togolese infants of 4-5 months and 8-10 months]. Tidjani O; Grunitzky B; Guérin N; Lévy-Bruhl D; Lecam N; Xuereff C; Tatagan K Bull Soc Pathol Exot; 1991; 84(5 Pt 5):873-84. PubMed ID: 1819435 [TBL] [Abstract][Full Text] [Related]
8. Immunisation of 4-6 month old Gambian infants with Edmonston-Zagreb measles vaccine. Whittle HC; Rowland MG; Mann GF; Lamb WH; Lewis RA Lancet; 1984 Oct; 2(8407):834-7. PubMed ID: 6148572 [TBL] [Abstract][Full Text] [Related]
9. Comparison of Edmonston-Zagreb and Schwarz strains of measles vaccine given by aerosol or subcutaneous injection. Khanum S; Uddin N; Garelick H; Mann G; Tomkins A Lancet; 1987 Jan; 1(8525):150-3. PubMed ID: 2879981 [TBL] [Abstract][Full Text] [Related]
10. Immune response to Edmonston-Zagreb measles virus strain in monovalent and combined MMR vaccine. Beck M; Smerdel S; Dedić I; Delimar N; Rajninger-Miholic M; Juzbasić M; Manhalter T; Vlatković R; Borcić B; Mihajić Z Dev Biol Stand; 1986; 65():95-100. PubMed ID: 3556780 [TBL] [Abstract][Full Text] [Related]
11. Measles antibody levels after vaccination with Edmonston-Zagreb and Schwarz measles vaccine at 9 months or at 9 and 18 months of age: a serological study within a randomised trial of different measles vaccines. Martins C; Garly ML; Bale C; Rodrigues A; Benn CS; Whittle H; Aaby P Vaccine; 2013 Nov; 31(48):5766-71. PubMed ID: 23994379 [TBL] [Abstract][Full Text] [Related]
12. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination. Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101 [TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of standard dose Edmonston-Zagreb measles vaccine in highland Papua New Guinean children from four months of age. Rogers S; Sanders RC; Alpers MP J Trop Med Hyg; 1991 Apr; 94(2):88-91. PubMed ID: 2023293 [TBL] [Abstract][Full Text] [Related]
14. [The development and duration of immunity in children vaccinated against measles with the Edmonston-Zagreb vaccine]. Borcić B; Smerdel S; Abu Eldan J; Kolić J; Ferdebar M; Kordić D; Mohacek N Lijec Vjesn; 1989; 111(4-5):131-4. PubMed ID: 2770398 [TBL] [Abstract][Full Text] [Related]
15. Aerosol measles vaccination in macaques: preclinical studies of immune responses and safety. de Swart RL; Kuiken T; Fernandez-de Castro J; Papania MJ; Bennett JV; Valdespino JL; Minor P; Witham CL; Yüksel S; Vos H; van Amerongen G; Osterhaus AD Vaccine; 2006 Sep; 24(40-41):6424-36. PubMed ID: 16934375 [TBL] [Abstract][Full Text] [Related]
16. Antibody persistence in Gambian children after high-dose Edmonston-Zagreb measles vaccine. Whittle HC; Campbell H; Rahman S; Armstrong JR Lancet; 1990 Oct; 336(8722):1046-8. PubMed ID: 1977029 [TBL] [Abstract][Full Text] [Related]
17. Measles antibody responses after early two dose trials in Guinea-Bissau with Edmonston-Zagreb and Schwarz standard-titre measles vaccine: better antibody increase from booster dose of the Edmonston-Zagreb vaccine. Garly ML; Balé C; Martins CL; Monteiro M; George E; Kidd M; Dias F; Aaby P; Whittle HC Vaccine; 2001 Feb; 19(15-16):1951-9. PubMed ID: 11228365 [TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy of three measles vaccines in Indian children. Banerjee K; Shaikh N; Phadke M; Bedekar SS; Rauta SK; Mehta JM Indian J Public Health; 1998; 42(4):113-9. PubMed ID: 10389523 [TBL] [Abstract][Full Text] [Related]
19. A long-term follow-up study on the efficacy of further attenuated live measles vaccine, Biken CAM vaccine. Isomura S; Morishima T; Nishikawa K; Hanada N; Rahman M; Terashima M; Kido S; Ueda S; Takahashi M Biken J; 1986 Mar; 29(1):19-26. PubMed ID: 3778422 [TBL] [Abstract][Full Text] [Related]
20. Immunologic studies of specific mucosal and systemic immune responses in Mexican school children after booster aerosol or subcutaneous immunization with measles vaccine. Bellanti JA; Zeligs BJ; Mendez-Inocencio J; García-Garcia ML; Islas-Romero R; Omidvar B; Omidvar J; Kim G; Fernandez De Castro J; Sepulveda Amor J; Walls L; Bellini WJ; Valdespino-Gomez JL Vaccine; 2004 Mar; 22(9-10):1214-20. PubMed ID: 15003650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]